✦ LIBER ✦
855 ONCE-DAILY REGIMENS OF THE HCV NS3/4A-PROTEASE INHIBITOR TMC435350 ARE PREDICTED TO PROVIDE THERAPEUTIC EXPOSURE IN PLASMA AND LIVER
✍ Scribed by G.A.E. van t Klooster; I. Vanwelkenhuysen; R. Hooijmaijers; K. Bol; M. Voets; J. Van Houdt; R.A.L. Verloes; F. Aharchi; K. Marien; P. Van Remoortere; F. Broeckaert; H. De Kock; K.A. Simmen
- Book ID
- 117376781
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 55 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.